Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Periodontal Research|March 1, 2003
Capsular polysaccharide from Actinobacillus actinomycetemcomitans inhibits IL-6 and IL-8 production in human gingival fibroblastYuko Ohguchi, Yuichi Ishihara, Masahiro Ohguchi, et al.
Journal of Cellular Biochemistry|March 5, 2009
IL-12 stimulates the osteoclast inhibitory peptide-1 (OIP-1/hSca) gene expression in CD4+ T cellsSrinivasan Shanmugarajan, Noriaki Kawanabe, Masanori Koide, et al.
International Journal of Molecular Sciences|November 9, 2019
The Regulation of Bone Metabolism and Disorders by Wnt SignalingKazuhiro Maeda, Yasuhiro Kobayashi, Masanori Koide, et al.
Journal of Periodontal Research|May 8, 2023
Sclerostin deficiency effectively promotes bone morphogenetic protein-2-induced ectopic bone formationKeigo Nakamura, Masanori Koide, Yasuhiro Kobayashi, et al.
European Journal of Pharmacology|July 5, 2019
Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile Paget diseaseToshihiro Tsuruda, Taro Funamoto, Nobuyuki Udagawa, et al.
Biochemical and Biophysical Research Communications|June 21, 2015
Wnt16 regulates osteoclast differentiation in conjunction with Wnt5aYasuhiro Kobayashi, Gnanasagar J Thirukonda, Yukio Nakamura, et al.
European Journal of Pharmacology|October 26, 2010
Prostaglandin E(2) receptor EP(4)-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiationTadashi Ninomiya, Akihiro Hosoya, Toru Hiraga, et al.
Endocrinology|January 8, 2013
Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male miceMasanori Koide, Yasuhiro Kobayashi, Tadashi Ninomiya, et al.
Endocrinology|September 28, 2020
The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In VivoTomoki Mori, Kanji Horibe, Masanori Koide, et al.
Plos One|September 23, 2017
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesisYuki Ozaki, Masanori Koide, Yuriko Furuya, et al.
Pageof 5